pharmcore inc tirzepatide Oral Tirzepatide: Dual-Incretin GLP-1 in

Clinical trials, patient reports, and medical literature provide insights into whether back pain is a recognized side effect

Resources We Trust Cleveland Clinic: GLP-1 Agonists Mayo Clinic: Pros and Cons of GLP-1 Agonists for Weight Loss National Association of Insurance Commissioners: Does Insurance Cover Weight Loss Injectables

Hypoglycaemia Treatment summaries

However, animal studies do not always predict how the drug will affect human pregnancies

also reported that treatment with liraglutide (0.6 3 mg daily) in seven patients with PWS (in combination with topiramate in 3 individuals), resulted in a variable response with a median weight loss of 9 kg over 96 weeks (37)

Commonly reported side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain